Johnson & Johnson (JNJ)
$227.46-1.45%
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Exceptional profit margins, a growing dividend, and a share price that already reflects the quality.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers product…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- $555.6B
Recent dividends
- 26 May 2026$1.34
- 24 Feb 2026$1.30
- 25 Nov 2025$1.30
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Johnson & Johnson and 1,600+ UK and US stocks.
Start free